Index RUT
P/E -
EPS (ttm) -2.14
Insider Own 58.50%
Shs Outstand 97.38M
Perf Week 26.33%
Market Cap 670.97M
Forward P/E -
EPS next Y -1.59
Insider Trans 15.84%
Shs Float 49.81M
Perf Month -3.45%
Income -198.13M
PEG -
EPS next Q -0.45
Inst Own 24.52%
Short Float 20.51%
Perf Quarter -15.43%
Sales 0.00M
P/S -
EPS this Y 18.57%
Inst Trans -
Short Ratio 13.53
Perf Half Y -12.93%
Book/sh 1.37
P/B 4.09
EPS next Y 10.16%
ROA -52.99%
Short Interest 10.21M
Perf Year -61.13%
Cash/sh 1.01
P/C 5.51
EPS next 5Y -
ROE -88.19%
52W Range 4.11 - 17.20
Perf YTD -36.91%
Dividend Est. -
P/FCF -
EPS past 5Y -193.88%
ROI -144.17%
52W High -67.50%
Beta 2.00
Dividend TTM -
Quick Ratio 2.53
Sales past 5Y -25.00%
Gross Margin -
52W Low 36.01%
ATR (14) 0.51
Dividend Ex-Date Sep 10, 2019
Current Ratio 2.53
EPS Y/Y TTM -45.24%
Oper. Margin 0.00%
RSI (14) 50.93
Volatility 11.92% 8.63%
Employees 234
Debt/Eq 0.10
Sales Y/Y TTM -
Profit Margin -
Recom 1.44
Target Price 15.50
Option/Short Yes / Yes
LT Debt/Eq 0.03
EPS Q/Q -61.42%
Payout -
Rel Volume 1.22
Prev Close 5.61
Sales Surprise -100.00%
EPS Surprise -29.50%
Sales Q/Q -
Earnings Mar 01 BMO
Avg Volume 755.14K
Price 5.59
SMA20 7.64%
SMA50 -15.85%
SMA200 -35.52%
Trades
Volume 923,365
Change -0.36%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-22-24 Initiated
Chardan Capital Markets
Buy
$17
Apr-08-24 Initiated
TD Cowen
Buy
Apr-03-24 Initiated
Wedbush
Outperform
$12
Jan-16-24 Downgrade
Stifel
Buy → Hold
$18 → $9
Dec-08-23 Initiated
Citigroup
Neutral
$10
Oct-09-23 Initiated
BMO Capital Markets
Outperform
$19
Jul-31-23 Initiated
Guggenheim
Buy
$24
Apr-18-23 Initiated
Stifel
Buy
$18
Nov-14-22 Initiated
Morgan Stanley
Equal-Weight
$23
Nov-14-22 Initiated
JP Morgan
Overweight
$27
Nov-14-22 Initiated
Jefferies
Buy
$25
Nov-14-22 Initiated
Goldman
Neutral
$22
Show Previous Ratings
May-03-24 12:00PM
May-01-24 08:00AM
Apr-30-24 06:01AM
Apr-29-24 10:12AM
07:35AM
07:33AM
Loading…
07:33AM
07:00AM
Apr-23-24 08:00AM
Mar-27-24 08:45AM
Mar-14-24 02:44PM
Mar-01-24 02:00PM
08:00AM
Feb-29-24 03:02AM
Feb-28-24 08:00AM
Feb-20-24 04:01PM
11:50PM
Loading…
Feb-14-24 11:50PM
04:05PM
Feb-01-24 08:00AM
Jan-25-24 08:00AM
Jan-09-24 06:21PM
Jan-05-24 05:00PM
08:00AM
Jan-02-24 08:00AM
Dec-19-23 10:30AM
Nov-30-23 07:45AM
Nov-08-23 08:00AM
Nov-03-23 04:01PM
Oct-30-23 03:46PM
Oct-27-23 06:00AM
Oct-24-23 07:30AM
05:04AM
Loading…
05:04AM
Oct-23-23 02:50AM
Oct-17-23 08:00AM
Oct-09-23 09:33AM
Sep-19-23 08:00AM
Aug-31-23 08:00AM
Aug-07-23 04:01PM
Jul-25-23 07:45AM
Jun-29-23 08:46AM
Jun-22-23 08:00AM
Jun-02-23 10:15AM
May-31-23 08:00AM
May-26-23 09:45AM
May-17-23 04:05PM
06:00AM
May-11-23 08:00AM
Mar-27-23 08:00AM
Mar-09-23 08:00AM
Feb-27-23 08:00AM
Jan-20-23 05:56AM
Jan-09-23 07:00AM
Jan-03-23 08:00AM
Nov-01-22 04:13PM
Oct-24-22 05:30PM
Oct-20-22 12:45PM
Oct-19-22 09:47PM
Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
ARCH Venture Partners XII, LLC 10% Owner Feb 15 '24 Buy 6.25 3,200,000 20,000,000 3,200,000 Feb 20 05:38 PM ARCH Venture Partners X, LLC 10% Owner Feb 15 '24 Buy 6.25 3,200,000 20,000,000 3,200,000 Feb 20 05:37 PM NELSEN ROBERT Director Feb 15 '24 Buy 6.25 3,200,000 20,000,000 3,200,000 Feb 20 05:41 PM GV 2019 GP, L.L.C. 10% Owner Jun 21 '23 Sale 14.97 19,003 284,496 0 Jun 22 05:03 PM GV 2019 GP, L.L.C. 10% Owner Jun 20 '23 Sale 15.06 37,405 563,248 0 Jun 22 05:03 PM GV 2019 GP, L.L.C. 10% Owner Jun 16 '23 Sale 15.02 6,532 98,109 0 Jun 20 04:17 PM GV 2019 GP, L.L.C. 10% Owner Jun 15 '23 Sale 14.92 66,659 994,326 0 Jun 20 04:17 PM GV 2019 GP, L.L.C. 10% Owner Jun 14 '23 Sale 14.87 28,960 430,684 0 Jun 15 04:22 PM GV 2019 GP, L.L.C. 10% Owner Jun 13 '23 Sale 15.13 28,100 425,102 0 Jun 15 04:22 PM GV 2019 GP, L.L.C. 10% Owner Jun 12 '23 Sale 14.98 16,031 240,151 0 Jun 13 04:20 PM GV 2019 GP, L.L.C. 10% Owner Jun 09 '23 Sale 14.48 15,672 226,984 0 Jun 13 04:20 PM GV 2019 GP, L.L.C. 10% Owner Jun 08 '23 Sale 15.74 5,000 78,686 0 Jun 09 04:24 PM GV 2019 GP, L.L.C. 10% Owner Jun 07 '23 Sale 16.92 15,000 253,871 0 Jun 09 04:24 PM GV 2019 GP, L.L.C. 10% Owner Jun 06 '23 Sale 17.02 29,975 510,166 0 Jun 07 04:17 PM GV 2019 GP, L.L.C. 10% Owner Jun 05 '23 Sale 16.70 22,434 374,612 0 Jun 07 04:17 PM GV 2019 GP, L.L.C. 10% Owner Jun 01 '23 Sale 14.36 45,223 649,194 0 Jun 02 04:17 PM GV 2019 GP, L.L.C. 10% Owner May 31 '23 Sale 13.65 16,633 227,004 0 Jun 02 04:17 PM GV 2019 GP, L.L.C. 10% Owner May 30 '23 Sale 13.70 16,805 230,240 0 May 31 04:15 PM GV 2019 GP, L.L.C. 10% Owner May 26 '23 Sale 13.70 12,602 172,603 0 May 31 04:15 PM GV 2019 GP, L.L.C. 10% Owner May 25 '23 Sale 13.38 23,161 309,973 0 May 26 04:17 PM GV 2019 GP, L.L.C. 10% Owner May 24 '23 Sale 13.66 7,900 107,920 0 May 26 04:17 PM GV 2019 GP, L.L.C. 10% Owner May 23 '23 Sale 14.74 43,939 647,648 0 May 24 05:07 PM GV 2019 GP, L.L.C. 10% Owner May 22 '23 Sale 14.13 87,922 1,242,092 0 May 24 05:07 PM GV 2019 GP, L.L.C. 10% Owner May 19 '23 Sale 13.88 63,212 877,066 0 May 22 04:21 PM GV 2019 GP, L.L.C. 10% Owner May 18 '23 Sale 13.04 27,098 353,271 0 May 22 04:21 PM GV 2019 GP, L.L.C. 10% Owner May 17 '23 Sale 12.77 15,000 191,600 10,735,324 May 18 04:16 PM GV 2019 GP, L.L.C. 10% Owner May 16 '23 Sale 12.59 50,649 637,676 10,750,324 May 18 04:16 PM GV 2019 GP, L.L.C. 10% Owner May 15 '23 Sale 12.74 157,952 2,012,087 10,800,973 May 16 04:16 PM GV 2019 GP, L.L.C. 10% Owner May 12 '23 Sale 12.72 27,290 347,222 10,958,925 May 16 04:16 PM GV 2019 GP, L.L.C. 10% Owner May 11 '23 Sale 13.13 26,626 349,533 10,986,215 May 12 04:16 PM GV 2019 GP, L.L.C. 10% Owner May 10 '23 Sale 14.03 87,397 1,225,804 11,012,841 May 12 04:16 PM GV 2019 GP, L.L.C. 10% Owner May 09 '23 Sale 14.08 321,238 4,522,613 11,100,238 May 10 04:17 PM GV 2019 GP, L.L.C. 10% Owner May 08 '23 Sale 14.13 100,772 1,423,727 11,421,476 May 10 04:17 PM
Index RUT
P/E -
EPS (ttm) -1.46
Insider Own 44.41%
Shs Outstand 197.86M
Perf Week 19.72%
Market Cap 2.31B
Forward P/E -
EPS next Y -1.30
Insider Trans 5.76%
Shs Float 123.02M
Perf Month 22.68%
Income -283.25M
PEG -
EPS next Q -0.30
Inst Own 40.46%
Short Float 21.72%
Perf Quarter 81.88%
Sales 0.00M
P/S -
EPS this Y 19.23%
Inst Trans 1.60%
Short Ratio 12.99
Perf Half Y 237.86%
Book/sh 1.45
P/B 7.18
EPS next Y -9.95%
ROA -40.81%
Short Interest 26.72M
Perf Year 89.82%
Cash/sh 0.94
P/C 11.05
EPS next 5Y -
ROE -72.00%
52W Range 2.74 - 12.00
Perf YTD 155.88%
Dividend Est. -
P/FCF -
EPS past 5Y -83.13%
ROI -74.85%
52W High -13.00%
Beta 1.62
Dividend TTM -
Quick Ratio 3.31
Sales past 5Y 0.00%
Gross Margin -
52W Low 280.33%
ATR (14) 0.62
Dividend Ex-Date -
Current Ratio 3.31
EPS Y/Y TTM -2.50%
Oper. Margin 0.00%
RSI (14) 67.15
Volatility 7.35% 6.44%
Employees 328
Debt/Eq 0.36
Sales Y/Y TTM -
Profit Margin -
Recom 1.67
Target Price 12.20
Option/Short Yes / Yes
LT Debt/Eq 0.32
EPS Q/Q -5.73%
Payout -
Rel Volume 1.61
Prev Close 9.78
Sales Surprise -
EPS Surprise -17.10%
Sales Q/Q -
Earnings Feb 29 AMC
Avg Volume 2.06M
Price 10.44
SMA20 19.57%
SMA50 14.48%
SMA200 78.07%
Trades
Volume 3,304,932
Change 6.75%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-16-24 Upgrade
H.C. Wainwright
Neutral → Buy
$12
Sep-25-23 Initiated
JMP Securities
Mkt Outperform
$9
Sep-05-23 Initiated
Citigroup
Buy
$8
Aug-14-23 Initiated
TD Cowen
Market Perform
May-02-23 Initiated
H.C. Wainwright
Neutral
Mar-01-21 Initiated
Morgan Stanley
Overweight
$40
Mar-01-21 Initiated
JP Morgan
Neutral
$35
Mar-01-21 Initiated
Goldman
Neutral
$40
Mar-01-21 Initiated
BofA Securities
Buy
$45
Apr-08-24 08:00AM
Mar-19-24 10:00AM
08:30AM
Mar-11-24 07:00PM
Mar-07-24 09:01AM
04:55PM
Loading…
Feb-29-24 04:55PM
(Associated Press Finance) -5.90%
04:05PM
03:02AM
Feb-28-24 04:05PM
Feb-13-24 04:05PM
Feb-12-24 04:05PM
Feb-08-24 01:22AM
Feb-07-24 04:01PM
Jan-27-24 11:02AM
Jan-18-24 12:00PM
10:24AM
Loading…
10:24AM
Jan-09-24 08:44AM
Jan-08-24 06:30AM
06:30AM
Jan-05-24 09:00AM
Jan-03-24 04:05PM
Dec-19-23 09:01AM
Dec-11-23 09:00AM
Dec-01-23 04:05PM
Nov-27-23 07:01PM
Nov-21-23 09:00AM
06:00AM
Nov-17-23 09:00AM
Nov-09-23 04:05PM
Nov-08-23 04:05PM
09:05AM
Loading…
Nov-02-23 09:05AM
Nov-01-23 10:30AM
Oct-19-23 10:30AM
Oct-10-23 04:15PM
Oct-02-23 07:00AM
Sep-27-23 08:31AM
Sep-11-23 06:30AM
Aug-30-23 04:05PM
Aug-29-23 09:00AM
Aug-03-23 05:03PM
(Associated Press Finance)
04:05PM
Jun-16-23 09:00AM
May-31-23 04:05PM
May-22-23 07:33AM
May-16-23 06:00AM
May-08-23 04:35PM
04:26PM
04:05PM
May-04-23 01:56PM
May-03-23 04:05PM
09:55AM
May-02-23 04:30PM
12:50PM
Apr-24-23 04:05PM
Apr-20-23 10:07AM
Apr-19-23 04:05PM
Apr-17-23 09:55AM
06:17AM
Apr-14-23 10:27AM
Apr-13-23 09:00AM
Apr-12-23 04:05PM
Apr-10-23 04:05PM
Mar-24-23 03:20PM
Mar-16-23 04:05PM
Mar-14-23 04:53PM
Mar-01-23 04:05PM
Feb-10-23 08:18AM
Feb-02-23 04:05PM
Jan-26-23 04:05PM
Jan-03-23 04:05PM
Dec-11-22 05:30PM
Dec-01-22 12:11AM
(American City Business Journals) -11.22%
Nov-30-22 10:55AM
(American City Business Journals) +5.94%
08:43AM
Nov-29-22 04:05PM
Nov-17-22 01:58PM
Nov-14-22 04:05PM
Nov-03-22 09:07AM
Nov-02-22 04:05PM
Oct-18-22 07:43AM
Sep-09-22 04:05PM
Sep-03-22 08:39AM
Aug-09-22 11:54AM
Aug-04-22 04:05PM
Jun-17-22 09:00AM
Jun-13-22 04:05PM
Jun-07-22 04:05PM
Jun-02-22 01:55AM
(American City Business Journals) +9.26%
Jun-01-22 04:05PM
May-12-22 05:40PM
May-11-22 07:19AM
(Simply Wall St.) -13.46%
May-10-22 04:05PM
May-04-22 04:05PM
May-02-22 04:35PM
Mar-24-22 04:12PM
Mar-20-22 08:02AM
Mar-16-22 08:30AM
Mar-09-22 04:05PM
Mar-08-22 04:35PM
Feb-28-22 09:00AM
Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Yang Patrick Y Director Mar 08 '24 Sale 9.45 25,000 236,300 149,250 Mar 11 04:57 PM NELSEN ROBERT Director Feb 08 '24 Buy 5.50 1,818,181 9,999,996 12,446,022 Feb 12 05:46 PM ARCH Venture Fund X, L.P. 10% Owner Feb 08 '24 Buy 5.50 1,818,181 9,999,996 12,446,022 Feb 12 05:43 PM CRANDELL KEITH 10% Owner Feb 08 '24 Buy 5.50 1,818,181 9,999,996 12,446,022 Feb 12 05:43 PM Hordo Christian EVP, Chief Business Officer Dec 15 '23 Sale 4.00 75,000 300,098 867,455 Dec 18 04:51 PM Flagship Ventures Fund V Gener 10% Owner Jun 07 '23 Sale 6.24 200,000 1,247,940 1,380,277 Jun 08 07:00 PM Flagship Ventures Fund V Gener 10% Owner Jun 06 '23 Sale 6.31 203,758 1,284,918 1,403,037 Jun 08 07:00 PM Flagship Ventures Fund V Gener 10% Owner May 26 '23 Sale 6.23 82,000 510,573 1,425,334 May 26 08:00 PM Flagship Ventures Fund V Gener 10% Owner May 25 '23 Sale 6.35 115,372 732,866 1,434,664 May 26 08:00 PM Flagship Ventures Fund V Gener 10% Owner May 24 '23 Sale 6.57 347,870 2,283,836 1,447,791 May 26 08:00 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite